TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,655,330 | -76.1% | 2,557,000 | -70.1% | 0.01% | -76.2% |
| Q2 2023 | $6,938,296 | -17.1% | 8,557,000 | +0.7% | 0.02% | -19.2% |
| Q1 2023 | $8,364,698 | +105.1% | 8,500,000 | +112.5% | 0.03% | +62.5% |
| Q3 2022 | $4,079,000 | +1.3% | 4,000,000 | 0.0% | 0.02% | -5.9% |
| Q2 2022 | $4,027,000 | -5.5% | 4,000,000 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $4,260,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| UBS OCONNOR LLC | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |